This Solicitation opportunity from Department Of Defense was posted on May 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
LIDOCAINE AND PRILO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of LIDOCAINE AND PRILOCAINE PERIODONTAL GEL, specifically the Oraqix product which contains 2.5% lidocaine and 2.5% prilocaine in a microemulsion form. Oraqix is supplied in dental cartridges, each containing 1.7 grams of gel, and these cartridges come individually blister-packaged along with a sterile blunt-tipped applicator meant for single use only. Packaging includes cartons of 20 cartridges per package, and the product has a total shelf life of 36 months, with a requirement that at least 31 months of shelf life remain upon receipt by the government. Storage conditions must be maintained at controlled room temperature between 20° to 25°C (68° to 77°F). The labeling and marking must conform to Medical Marking Standard No. 1A, superseding prior military specifications. The contract requires that all packaging be commercial, properly sealed to protect against damage and breakage during transit, and suitable for safe delivery through normal shipping carriers at the lowest cost. The shipment inspection and acceptance points are both at the destination with a strict quantity variance tolerance of zero percent. This acquisition is regulated by the FDA, and contracting officers must coordinate with product specialists for confirmation. The product is identified by NSN 6505-01-656-9640, with delivery expected within 20 days to the designated location. The contract emphasizes adherence to applicable DLA technical and quality standards, including specialized packaging, marking, and handling of hazardous materials where necessary, ensuring compliance with all regulatory and defense logistics requirements.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
LIDOCAINE AND PRILOCAINE, PERIODONTAL GEL.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RX ONLY. UNIT OF ISSUE IS A PACKAGE CONTAINING 20 CARTRIDGES. ORAQIX
(LIDOCAINE AND PRILOCAINE PERIODONTAL GEL,) 2.5%/2.5% IS A
MICROEMULSION.. ORAQIX (LIDOCAINE AND PRILOCAINE PERIODONTAL GEL),
2.5%/2.5%, IS SUPPLIED IN DENTAL CARTRIDGES THAT PROVIDE 1.7G GEL.
INDIVIDUALLY BLISTER-PACKAGED CARTRIDGES OF ORAQIX ARE DISTRIBUTED IN A
CARTON OF 20.. EACH INDIVIDUAL BLISTER PACKAGE ALSO CONTAINS A STERILE
BLUNT-TIPPED APPLICATOR. EACH BLUNT-TIPPED APPLICATOR IS FOR SINGLE USE
ONLY. TOTAL SHELF LIFE IS 36 MONTHS.. THERE SHALL BE A MINIMUM OF 31
MONTHS OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT BY THE FIRST
GOVERNMENT ACTIVITY.. STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP
CONTROLLED ROOM TEMPERATURE]. LABELING AND MARKING MUST IN ACCORDANCE
WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013. 08/02/2016
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil.
SPE2DP-26-T-3260
SECTION B
MMS NO. 1 IS ALSO AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BOEING DISTRIBUTION, INC. 22819 P/N 69-42136-36 THE BOEING COMPANY 81205 P/N 69-42136-36
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016637619 0001 PG 1.000
NSN/MATERIAL:6505016569640
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
IP025: PACKAGING, MARKING, AND SHIPPING OF HAZARDOUS MATERIALS
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
SPE2DP-26-T-3260
SECTION B
PR: 7016637619 PRLI: 0001 CONT’D
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
FM5270
FM5270 18 MDSS SGSM
CP 011 81 98 938 1111 EXT 634 4572
KADENA AB BLDG 3154
KADENA AB OKINAWA 904 0200
JP
MEDICAL AIR BRIDGE WEST. FOR ELIGIBLE ITEMS: SD0379. CARDINAL HEALTH, 4551 EAST PHILADELPHIA ST ONTARIO,
CA (TEXT IN ENHANCEMENT)
M/F: (TCN) FM527061240267
RDD:
PROJ: TP 3
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:05/07/2026
SPE2DP-26-T-3260 NSN/Part Number: 6505-01-656-9640 Quantity: 1 PG Purchase Request: 7016637619QTY: 1 Delivery: 20 days ADO